Comparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological study

scientific article

Comparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological study is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...863677S
P356DOI10.1371/JOURNAL.PONE.0063677
P932PMC publication ID3665786
P698PubMed publication ID23723992
P5875ResearchGate publication ID236978547

P50authorIsabelle BoutronQ20090328
Philippe RavaudQ37368509
Ludovic TrinquartQ37836849
P2093author name stringValérie Seegers
P2860cites workThe challenges of clinical trials in the exclusion zone: the case of the frail elderly.Q40057608
Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological studyQ41111726
Including older people in clinical researchQ42671444
Balancing benefits and harms in health care.Q42784217
Meta-analysis and the meta-epidemiology of clinical researchQ42785474
EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumorsQ43793625
Interpretation of random effects meta-analyses.Q43810883
Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelinesQ44283416
Comparative effectiveness of medical interventions in adults versus childrenQ44695978
The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic studyQ45073390
Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic studyQ45228027
The quality of pharmacologic care for vulnerable older patientsQ46097111
Participation of patients 65 years of age or older in cancer clinical trialsQ48006693
A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trialsQ52032770
Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' researchQ52036957
Multivariable modelling for meta-epidemiological assessment of the association between trial quality and treatment effects estimated in randomized clinical trialsQ53013525
Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice changeQ53064501
Reporting of Safety Results in Published Reports of Randomized Controlled TrialsQ57286555
Improving the Quality of Medication Use in Elderly PatientsQ58071028
The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart FailureQ60723673
Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levelsQ73031726
Underrepresentation of patients 65 years of age or older in cancer-treatment trialsQ73311140
Drug therapy in the elderly: improving quality and accessQ73356811
Can quality of clinical trials and meta-analyses be quantified?Q77326667
Geriatric oncology aims for clinical trialsQ79319666
Age-based exclusions from cardiovascular clinical trials: implications for elderly individuals (and for all of us): comment on "the persistent exclusion of older patients from ongoing clinical trials regarding heart failure"Q83737779
Why the exclusion of older people from clinical research must stopQ84187295
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studiesQ24282604
Quality of Cochrane reviews: assessment of sample from 1998Q24555211
The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsQ27860509
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsQ27860735
Meta-analysis in clinical trialsQ27860779
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study InvestigatorsQ28372091
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?Q29619328
The hazards of scoring the quality of clinical trials for meta-analysisQ29619369
Interaction revisited: the difference between two estimatesQ29619619
Comparison of evidence of treatment effects in randomized and nonrandomized studiesQ30699759
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse dataQ30926358
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trialsQ33285346
Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overviewQ33894784
Completeness of safety reporting in randomized trials: an evaluation of 7 medical areasQ33937374
Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugsQ34221473
Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling reviewQ34610692
Representation of the elderly, women, and minorities in heart failure clinical trialsQ34769936
Improving medication use for older adults: an integrated research agendaQ35215906
The exclusion of the elderly and women from clinical trials in acute myocardial infarctionQ35765397
Cautionary tales in the interpretation of clinical studies involving older personsQ37729624
Improving recruitment of older people to research through good practiceQ37930797
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
P304page(s)e63677
P577publication date2013-01-01
P1433published inPLOS OneQ564954
P1476titleComparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological study
P478volume8

Reverse relations

Q38343604Drug therapies in older adults (part 1).cites workP2860

Search more.